Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.

Nio Y, Sasai M, Akahori Y, Okamura H, Hasegawa H, Oshima M, Watashi K, Wakita T, Ryo A, Tanaka Y, Hijikata M.

Antiviral Res. 2019 Sep;169:104537. doi: 10.1016/j.antiviral.2019.104537. Epub 2019 Jun 14.

PMID:
31207277
2.

Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication.

Hishiki T, Kato F, Nio Y, Watanabe S, Wen Tan NW, Yamane D, Miyazaki Y, Lin CC, Suzuki R, Tajima S, Lim CK, Saijo M, Hijikata M, Vasudevan SG, Takasaki T.

Antiviral Res. 2019 May;165:42-46. doi: 10.1016/j.antiviral.2019.03.002. Epub 2019 Mar 7.

PMID:
30853381
3.

Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension.

Muraki Y, Naito T, Tohyama K, Shibata S, Kuniyeda K, Nio Y, Hazama M, Matsuo T.

Biosci Biotechnol Biochem. 2019 Jun;83(6):1000-1010. doi: 10.1080/09168451.2019.1584520. Epub 2019 Mar 5.

PMID:
30835622
4.

[A Retrospective Analysis on Comparative Treatment Results for Breast Cancer between Elderly Women Aged 70 and More Than 80 Years].

Nio Y, Imai S, Sakamoto M, Uesugi K, Tamaoki M, Tamaoki M.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1283-1289. Japanese.

PMID:
30237369
5.

Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.

Nio Y, Akahori Y, Okamura H, Watashi K, Wakita T, Hijikata M.

Biochem Biophys Res Commun. 2018 Jun 27;501(3):820-825. doi: 10.1016/j.bbrc.2018.04.199. Epub 2018 May 4.

PMID:
29723527
6.

Bombesin receptor subtype-3-expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus.

Maruyama M, Hotta N, Nio Y, Hamagami K, Nagi T, Funata M, Sakamoto J, Nakakariya M, Amano N, Nishida M, Okawa T, Arikawa Y, Sasaki S, Kasai S, Nagisa Y, Habata Y, Mori M.

Brain Behav. 2017 Dec 15;8(1):e00881. doi: 10.1002/brb3.881. eCollection 2018 Jan.

7.

Podocan Is Expressed in Blood and Adipose Tissue and Correlates Negatively With the Induction of Diabetic Nephropathy.

Nio Y, Okawara M, Okuda S, Matsuo T, Furuyama N.

J Endocr Soc. 2017 May 16;1(7):772-786. doi: 10.1210/js.2017-00123. eCollection 2017 Jul 1.

8.

Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.

Nio Y, Tanaka M, Hirozane Y, Muraki Y, Okawara M, Hazama M, Matsuo T.

FASEB J. 2017 Dec;31(12):5307-5320. doi: 10.1096/fj.201700249R. Epub 2017 Aug 10.

PMID:
28798156
9.

[Third- and Fourth-Line Chemotherapies including Paclitaxel and Bevacizumab for Metastatic Breast Cancer].

Sakamoto M, Nio Y, Imai S, Uesugi K, Tamaoki M, Tamaoki M.

Gan To Kagaku Ryoho. 2017 Jul;44(7):579-584. Japanese.

PMID:
28790261
10.

A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Male Diet-Induced-Obese Rats With Circadian Rhythm Change.

Nio Y, Hotta N, Maruyama M, Hamagami K, Nagi T, Funata M, Sakamoto J, Nakakariya M, Amano N, Okawa T, Arikawa Y, Sasaki S, Okuda S, Kasai S, Habata Y, Nagisa Y.

Endocrinology. 2017 May 1;158(5):1298-1313. doi: 10.1210/en.2016-1825.

PMID:
28324017
11.

[A Multivariate Analysis of the Efficacy of Adjuvant Chemotherapy in Triple-Negative Breast Cancer].

Nio Y, Imai S, Uesugi K, Tamaoki M, Tamaoki M, Maruyama R.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1187-1192. Japanese.

PMID:
27760935
12.

Liver-specific mono-unsaturated fatty acid synthase-1 inhibitor for anti-hepatitis C treatment.

Nio Y, Hasegawa H, Okamura H, Miyayama Y, Akahori Y, Hijikata M.

Antiviral Res. 2016 Aug;132:262-7. doi: 10.1016/j.antiviral.2016.07.003. Epub 2016 Jul 5.

PMID:
27392483
13.

Fatty acid biosynthesis is involved in the production of hepatitis B virus particles.

Okamura H, Nio Y, Akahori Y, Kim S, Watashi K, Wakita T, Hijikata M.

Biochem Biophys Res Commun. 2016 Jun 17;475(1):87-92. doi: 10.1016/j.bbrc.2016.05.043. Epub 2016 May 10.

PMID:
27178211
14.

A rare case of non-invasive ductal carcinoma of the breast coexisting with follicular lymphoma: A case report with a review of the literature.

Tamaoki M, Nio Y, Tsuboi K, Nio M, Tamaoki M, Maruyama R.

Oncol Lett. 2014 Apr;7(4):1001-1006. Epub 2014 Feb 14.

15.

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.

Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of Pancreas Screening (CAPS) Consortium.

Gut. 2013 Mar;62(3):339-47. doi: 10.1136/gutjnl-2012-303108. Epub 2012 Nov 7. Erratum in: Gut. 2014 Dec;63(12):1978. Hammell, Pascal [corrected to Hammel, Pascal]. Gut. 2014 Jan;63(1):178. Hamell, Pascal [corrected to Hammell, Pascal].

16.

Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.

Nio Y, Yamauchi T, Iwabu M, Okada-Iwabu M, Funata M, Yamaguchi M, Ueki K, Kadowaki T.

Diabetologia. 2012 Dec;55(12):3350-8. doi: 10.1007/s00125-012-2710-2. Epub 2012 Sep 16.

PMID:
22983634
17.

Lymphoepithelioma-like carcinoma of the breast: a case report with a special analysis of an association with human papilloma virus.

Nio Y, Tsuboi K, Tamaoki M, Tamaoki M, Maruyama R.

Anticancer Res. 2012 Apr;32(4):1435-41.

PMID:
22493382
18.

Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis.

Cahen DL, Gouma DJ, Laramée P, Nio Y, Rauws EA, Boermeester MA, Busch OR, Fockens P, Kuipers EJ, Pereira SP, Wonderling D, Dijkgraaf MG, Bruno MJ.

Gastroenterology. 2011 Nov;141(5):1690-5. doi: 10.1053/j.gastro.2011.07.049. Epub 2011 Aug 16.

PMID:
21843494
19.

Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.

Akagi Y, Nio Y, Shimada S, Aoyama T.

Biol Pharm Bull. 2011;34(2):233-7.

20.

Ductal carcinoma in situ arising within a benign phyllodes tumor: A case report with a review of the literature.

Nio Y, Iguchi C, Tsuboi K, Maruyama R.

Oncol Lett. 2011 Mar;2(2):223-228. Epub 2010 Dec 8.

21.

Practice and yield of early CT scan in acute pancreatitis: a Dutch Observational Multicenter Study.

Spanier BW, Nio Y, van der Hulst RW, Tuynman HA, Dijkgraaf MG, Bruno MJ.

Pancreatology. 2010;10(2-3):222-8. doi: 10.1159/000243731. Epub 2010 May 17.

PMID:
20484959
22.

Green urine, but no infection.

Bolmers MD, Linthorst GE, Soeters MR, Nio YC, van Lieshout JJ.

Lancet. 2009 Oct 31;374(9700):1566. doi: 10.1016/S0140-6736(09)61295-2. No abstract available.

PMID:
19880022
23.

Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction.

Nio Y, Iguchi C, Itakura M, Nishi T, Hashimoto K, Takeda H, Takamura M, Omori H, Sato Y, Koike M, Endo S.

Anticancer Res. 2009 Aug;29(8):3329-35.

24.

Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice.

Otani K, Kitayama J, Yasuda K, Nio Y, Iwabu M, Okudaira S, Aoki J, Yamauchi T, Kadowaki T, Nagawa H.

Cancer Lett. 2010 Feb 28;288(2):177-82. doi: 10.1016/j.canlet.2009.06.037. Epub 2009 Jul 30.

PMID:
19646806
25.

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van Eijck CH, Cats A, Kuipers EJ, Nio Y, Fockens P, Bruno MJ.

Am J Gastroenterol. 2009 Sep;104(9):2175-81. doi: 10.1038/ajg.2009.276. Epub 2009 Jun 2.

PMID:
19491823
26.

High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders.

Nio Y, Iguchi C, Itakura M, Toga T, Hashimoto K, Koike M, Omori H, Sato Y, Endo S.

Anticancer Res. 2009 May;29(5):1607-10.

27.

Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.

Kluijt I, Cats A, Fockens P, Nio Y, Gouma DJ, Bruno MJ.

J Clin Gastroenterol. 2009 Oct;43(9):853-7. doi: 10.1097/MCG.0b013e3181981123.

PMID:
19417680
28.

[Surgical drainage of the pancreatic duct in patients with chronic pancreatitis is more effective than endoscopic drainage: randomized trial].

Cahen DL, Gouma DJ, Nio Y, Rauws EA, Boermeester MA, Busch OR, Stoker J, Laméris JS, Dijkgraaf MG, Huibregtse K, Bruno MJ.

Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2624-30. Dutch.

PMID:
18161265
29.

GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.

Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, Wei S, Hashimoto A, Yamada A, Yano H, Mazaki Y, Kodama H, Nio Y, Manabe T, Wada H, Kobayashi H, Sabe H.

Nat Cell Biol. 2008 Jan;10(1):85-92. Epub 2007 Dec 16.

PMID:
18084281
30.

[Evaluation of therapeutic regimens for taxane-resistant recurrent/metastatic breast cancer].

Kan N, Yoshikawa K, Nio Y, Iguchi C, Kodama H.

Gan To Kagaku Ryoho. 2007 Jul;34(7):1047-52. Japanese.

PMID:
17637540
32.

Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis.

Cahen DL, Gouma DJ, Nio Y, Rauws EA, Boermeester MA, Busch OR, Stoker J, Laméris JS, Dijkgraaf MG, Huibregtse K, Bruno MJ.

N Engl J Med. 2007 Feb 15;356(7):676-84.

33.

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.

Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, Ito Y, Kamon J, Tsuchida A, Kumagai K, Kozono H, Hada Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Awazawa M, Takamoto I, Froguel P, Hara K, Tobe K, Nagai R, Ueki K, Kadowaki T.

Nat Med. 2007 Mar;13(3):332-9. Epub 2007 Feb 1.

PMID:
17268472
34.

Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.

Nio Y, Iguchi C, Kodama H, Itakura M, Hashimoto K, Koike M, Toga T, Maruyama R, Fukushima M.

Oncol Rep. 2007 Jan;17(1):153-9.

PMID:
17143493
36.

Computed tomography colonography: current issues.

Nio Y, Van Gelder RE, Stoker J.

Scand J Gastroenterol Suppl. 2006;(243):139-45. Review.

PMID:
16782633
37.

Immunohistochemical expression of HER-1 and HER-2 in extrahepatic biliary carcinoma.

Ogo Y, Nio Y, Yano S, Toga T, Koike M, Hashimoto K, Itakura M, Maruyama R.

Anticancer Res. 2006 Jan-Feb;26(1B):763-70.

38.

Segmentation and size measurement of polyps in CT colonography.

Dijkers JJ, van Wijk C, Vos FM, Florie J, Nio YC, Venema HW, Truyen R, van Vliet LJ.

Med Image Comput Comput Assist Interv. 2005;8(Pt 1):712-9.

PMID:
16685909
39.

[Pancreatic acinar cell carcinoma successfully treated with combination of oral TS-1 and intra-arterial cisplatin].

Kataoka Y, Nio Y, Yano S, Koike M, Hashimoto K, Itakura M, Itagaki T, Nishi T, Endo S, Higami T.

Gan To Kagaku Ryoho. 2006 Apr;33(4):525-8. Japanese.

PMID:
16612167
40.

[Comparison of pBcl-2 and pBax expression in primary invasive ductal pancreatic cancer between Chinese and Japanese patients].

Zhou JP, Dong M, Nio Y, Kong FM, Zheng XY, Guo KJ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):611-4. Chinese.

PMID:
16274043
41.

Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.

Nio Y, Omori H, Hashimoto K, Itakura M, Koike M, Yano S, Toga T, Higami T, Maruyama R.

Anticancer Res. 2005 Sep-Oct;25(5):3523-9.

42.

Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.

Nio Y, Hashimoto K, Yano S, Itakura M, Koike M, Yamaguchi K, Endo S, Tsuji M, Higami T, Maruyama R.

Oncol Rep. 2005 Aug;14(2):401-8.

PMID:
16012722
43.
44.

Influence of the rate of contrast change on the quality of contrast sensitivity assessment: a comparison of three psychophysical methods.

Nio YK, Jansonius NM, Lamers P, Mager A, Zeinstra J, Kooijman AC.

Ophthalmic Physiol Opt. 2005 Jan;25(1):18-26.

PMID:
15649179
45.
46.

A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.

Nio Y, Koike M, Omori H, Hashimoto K, Itakura M, Yano S, Higami T, Maruyama R.

Anticancer Res. 2004 May-Jun;24(3b):1879-87.

47.
48.

Effect of methods of myopia correction on visual acuity, contrast sensitivity, and depth of focus.

Nio YK, Jansonius NM, Wijdh RH, Beekhuis WH, Worst JG, Norrby S, Kooijman AC.

J Cataract Refract Surg. 2003 Nov;29(11):2082-95.

PMID:
14670416
49.

Effect of intraocular lens implantation on visual acuity, contrast sensitivity, and depth of focus.

Nio YK, Jansonius NM, Geraghty E, Norrby S, Kooijman AC.

J Cataract Refract Surg. 2003 Nov;29(11):2073-81.

PMID:
14670415
50.

Ileocecal valve-preserving ileostomy after total proctocolectomy--a novel technique for ileostomy.

Nio Y, Itakura M, Yamaguchi K, Hirahara N.

Dig Surg. 2004;21(1):7-9. Epub 2003 Nov 21.

PMID:
14639037

Supplemental Content

Support Center